NCT06559605 Evaluation of Bone Gain Using Customized 3D Zirconia Barrier Versus Titanium Mesh
| NCT ID | NCT06559605 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cairo University |
| Condition | Bone Loss, Alveolar |
| Study Type | INTERVENTIONAL |
| Enrollment | 26 participants |
| Start Date | 2024-05-22 |
| Primary Completion | 2026-05-22 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 26 participants in total. It began in 2024-05-22 with a primary completion date of 2026-05-22.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Evaluation of clinical and radiographical amount of bone gained using customized 3D printed zirconia barrier compared to titanium mesh in combined ridge defect at the esthetic zone.
Eligibility Criteria
Inclusion Criteria: * Age: 20-70 years. * Bone width less than 4mm * Vertical bone height less than 9mm * Periodontally sound neighboring teeth * Patients with sound vertical occlusal bite dimension * Good oral hygiene (full mouth plaque control record \[PCR\] \< 25%,full mouth bleeding on probing (BOP) \< 25% . * Patients demonstrating understanding and commitment to the post-operative care regime and the study follow up timeline. * Good general health (including participants with well-controlled systemic disease) Exclusion Criteria: 1. Pathological lesions (abscess-cyst-acute infection) in the defect site 2. Systemic diseases that would interfere with bone metabolism 3. Uncontrolled diabetic patients 4. Ongoing treatment or a history of recent chemotherapy or radiotherapy 5. Poor oral hygiene after hygienic phase (Plaque control record over 30%) or Active periodontal disease
Contact & Investigator
Hani El Nahass
STUDY DIRECTOR
Cairo University
Frequently Asked Questions
Who can join the NCT06559605 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 70 Years, studying Bone Loss, Alveolar. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06559605 currently recruiting?
Yes, NCT06559605 is actively recruiting participants. Contact the research team at amaalabdalnassar@gmail.com for enrollment information.
Where is the NCT06559605 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT06559605 clinical trial?
NCT06559605 is sponsored by Cairo University. The principal investigator is Hani El Nahass at Cairo University. The trial plans to enroll 26 participants.